|
인쇄하기
취소
|
Deregulation to spur commissioned drug markers
Published: 2009-10-21 07:00:00
Updated: 2009-10-21 07:00:00
Rigid regulations are making it difficult for commissioned pharmaceutical manufacturers to sell any drugs without omission of clinical trials.
The government said on October 16 that rules governing the commissioned pharmaceutical firms will be eased to gain greater efficiency and synergy in the sector.
Under the newly revised pharmaceutical laws, the government elaborated that a commissio...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.